Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v7-FR
Language French French
Date Updated 2020-10-22 2020-08-13
Drug Identification Number 02340615 02340615
Brand name TEVA-DONEPEZIL TEVA-DONEPEZIL
Common or Proper name DONEPEZIL HCL 10MG TAB DONEPEZIL HCL 10MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients DONEPEZIL HYDROCHLORIDE DONEPEZIL HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code N06DA N06DA
ATC description ANTI-DEMENTIA DRUGS ANTI-DEMENTIA DRUGS
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2020-07-14 2020-07-14
Estimated end date 2021-02-28 2020-12-31
Actual end date 2020-10-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Allocating 100% of Teva market share for duration of risk period.
Health Canada comments